Saturday 17 October 2026
Export SBC’s income statement to Excel — free account
SBC Medical Group Holdings Incorporated
SBC Industrials Consulting Services
SBC Medical Group Holdings Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $173.6 million, down 15.5% from fiscal 2024. In the quarter to June 2026, revenue grew 13.4%, EPS grew 400.0%, free cash flow grew 396.1% and total debt rose 420.7%, each against the same quarter a year earlier. Dividend growth for five consecutive years.
5.16
0.14
−2.64%
Follow SBC
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
10.59 | 8.80 | 10.72 | 6.55 |
P/S ratio |
2.50 | 2.56 | 2.53 | 1.80 | |
P/FCF ratio |
0.00 | 14.91 | 11.60 | 4.75 | |
P/Operating CF |
(21.33) | 8.54 | 46.44 | 14.04 | |
P/B ratio |
1.80 | 1.69 | 1.59 | 1.13 | |
Price to Tangible BV |
2.03 | 2.22 | 2.06 | 1.44 | |
EV/Sales |
1.90 | 1.86 | 1.78 | 0.97 | |
EV/EBITDA |
5.45 | 4.60 | 4.73 | 2.46 | |
EV/Operating CF |
(9.81) | 13.08 | 9.44 | 2.69 | |
EV/FCF |
(10.02) | 10.84 | 8.16 | 2.55 | |
Quick Ratio |
4.51 | 3.34 | 3.39 | 3.00 | |
Current Ratio |
5.10 | 3.78 | 3.82 | 3.31 | |
Net Debt/EBITDA |
(6.39) | (8.96) | (6.91) | (7.31) | |
Debt/Assets |
6.62% | 11.29% | 10.44% | 9.30% | |
Debt/Equity |
0.09 | 0.16 | 0.15 | 0.14 | |
Asset Turnover |
0.58 | 0.54 | 0.50 | 0.49 | |
Operating CF/Net income |
(1.63) | 3.66 | 0.82 | 2.11 | |
Capex/Depreciation |
1.14 | 5.63 | (0.82) | (0.41) | |
Interest Coverage |
326.77 | 229.04 | 154.36 | 147.44 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
33.98% | 40.64% | 29.32% | 34.60% | |
Intangible Assets out of Total Assets |
0.09 | 0.17 | 0.16 | 0.15 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.02% | |
Graham Net Nets |
0.35 | 0.26 | 0.28 | 0.42 | |
Graham Number |
4.72 | 5.31 | 4.81 | 5.37 | |
Earnings Yield |
9.45% | 11.37% | 9.33% | 15.26% | |
Free Cash Flow Yield |
(7.60%) | 6.71% | 8.62% | 21.03% | |
Revenue per Share |
0.42 | 0.38 | 0.42 | 0.48 | |
Operating CF per Share |
(0.20) | 0.50 | 0.09 | 0.22 | |
Capex per Share |
0.01 | 0.04 | (0.01) | 0.00 | |
Free Cash Flow per Share |
(0.20) | 0.54 | 0.08 | 0.21 | |
Cash per Share |
1.24 | 1.59 | 1.63 | 1.80 | |
Shareholders Equity per Share |
2.42 | 2.56 | 2.64 | 2.73 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
2.42 | 2.56 | 2.64 | 2.73 | |
Free Cash Flow |
(20.03) | 55.76 | 8.68 | 22.04 | |
Working Capital |
182.62 | 170.10 | 176.21 | 180.93 | |
Capital Expenditures |
0.85 | 3.80 | (0.55) | (0.46) | |
Net Current Asset Value |
153.90 | 114.08 | 121.14 | 132.64 | |
EV/EBIT |
5.72 | 4.78 | 4.95 | 2.59 | |
Capex to Sales |
(0.02) | (0.10) | 0.01 | 0.01 | |
Price to Operating Income |
7.51 | 6.58 | 7.03 | 4.83 | |
| Other line items | |||||
Average Receivables |
59.77 | 40.21 | 42.85 | 57.27 | |
Average Payables |
17.49 | 16.09 | 19.35 | 21.65 | |
Average Inventory |
1.83 | 2.14 | 2.01 | 2.34 | |
Average Assets |
308.92 | 323.27 | 336.31 | 360.98 | |
Average Common Equity |
226.79 | 229.16 | 248.35 | 262.28 |
Columns are period end dates